1. Home
  2. Live Updates
  3. Silverback therapeutics

Live Breaking News & Updates on Silverback Therapeutics

Stay updated with breaking news from Silverback therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biophytis (NASDAQ:BPTS) vs. Silverback Therapeutics (NASDAQ:SBTX) Head to Head Analysis

Silverback Therapeutics (NASDAQ:SBTX – Get Free Report) and Biophytis (NASDAQ:BPTS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability. Profitability This table compares Silverback Therapeutics and Biophytis’ […] ....

United States , France General , Silverback Therapeutics Inc , Silverback Therapeutics , Get Free Report , Given Biophyti , Silverback Therapeutics Daily ,

Moderna : AACR INT Head & Neck Poster -April 08, 2024 at 04:52 pm EDT

CT141




mRNA-4157 Individualized Neoantigen Therapy +. ....

United Kingdom , North Carolina , United States , San Diego , New York , Duke University Medical Center , Cleveland Clinic , Manishr Patel , Jeffreym Clarke , Martin Gutierrez , Acerta Pharma , Immunitas Incyte , Genentech Roche , Daiichi Sankyo , Zhaojie Zhang , Justinf Gainor , Roberts Meehan , Bluedot Bio , Janicem Mehnert , Peijie Hou , Manju Morrissey , Vasudha Sehgal , Anjali Rao , Lakshmi Srinivasan , Juliee Bauman , Shyam Srivats ,

Neoadjuvant Durvalumab Plus Chemo Boosts pCR Vs Chemo Alone in Gastric/GEJ Cancers Regardless of Region

Durvalumab plus neoadjuvant FLOT improved pCR vs chemotherapy alone in patients with resectable gastric and GEJ cancers, irrespective of region. ....

United States , Durvalumab Imfinzi , Merck Serono , Eli Lilly , Genentech Roche , Amerisource Bergen , Basilea Pharmaceutica , Yelena Janjigian , Peerview Institute , Research To Practice , Michaelj Hennessy Associates , Zymeworks Inc , Guardant Health Inc , Gene Pharma Inc , Paradigm Medical Communications , Lynx Health , Fred Team , Department Of Defense , Bristol Myers Squibb , Cancers Symposium , North America , South America , Gastrointestinal Oncology Service , Memorial Sloan Kettering Cancer Center , Arcus Biosciences , Ask Gene Pharma ,

Capstan Therapeutics Appoints Ramin Farzaneh-Far, M.D., as Chief Medical Officer and Announces Key Business Leadership Promotion

SAN DIEGO (BUSINESS WIRE) Jan 8, 2024 ....

United Kingdom , San Francisco , United States , Rhiannon Jeselonis , Los Angeles , Ramin Farzaneh , Miguel Arcinas , Laura Shawver , Gilead Sciences , University Of California , Ira Pharmaceuticals , University Of Chicago Booth School Business , Capstan Therapeutics Inc , Corporate Development , University College London , University Of Cambridge , Capstan Therapeutic Inc , Ramin Farzaneh Far , Chief Medical Officer , Senior Vice President , Chief Executive Officer , Venture Partner , Akebia Therapeutics , Vice President , Investor Relations , Silverback Therapeutics ,

Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19

This randomized study examines the effect of higher-dose fluvoxamine on time to sustained recovery from mild to moderate COVID-19 or progression to severe disea ....

United States , Quintero Cardona , Pardes Biosciences , Bristol Myers Squibb , Susanna Naggie , Eli Lilly , Novo Nordisk , Department Of Defense , Translational Sciences , University Of Pittsburgh , Cincinnati Children Hospital Medical Center , John Hopkins University , Or Foundation , Health Insights , Us Biomedical Advanced Research Development Authority , Vanderbilt University Medical Center Clinical , Duke University School Of Medicine , Health Sciences , National Institutes Of Health , Office Of The , Enanta Pharmaceuticals , National Center , National Institute Of Health , Government Services , Study Group , Duke Clinical Research Institute ,